International Business Systems’ approach to ERP systems in light of the DSCSA requirements.
The bioreactor market's first disposable and scalable solution.
Simon Boa from EMD Millipore participates in a Q&A about the benefits and challenges of (as well as the demand for) biosimilars.
How pharmaceutical manufacturers can use global pricing data and advanced analytics for better decisions and a competitor’s edge.
How to implement PAT to efficiently remove solvents in pharmaceutical processes.
Many people are calling for a change in the pharmaceutical industry, and that change is simply (and primarily): drugs should cost less.
Fighting flu with designer drugs: a new compound fends off different influenza strains.
C. diff study provides insight into antibiotic resistance and risks for infection.
Affinivax secures additional funding to advance its novel pneumococcal vaccine towards clinical trials.
Microbix Biosystems Inc. announced plans to develop and introduce new products for use in diagnostic tests and vaccine research in response to the emergent Zika virus.